Phenotype measures set:   Wiltshire3   ACTH

ID, description, units MPD:38101   ACTH   cerebral cortex ACTH, relative fluorescence intensity  
fluoxetine study
Measures • control    • fluoxetine    • change index
Data set, strains Wiltshire3   inbred   30 strains     sex: m     age: 10-11wks
Procedure biomarker quantification
Comparisoncontrol group vs. treated group
Availability note:Individual animal data were not submitted. Some functionality not available.
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Wiltshire3 - cerebral cortex ACTH, relative fluorescence intensity







  INDIVIDUAL MEASURES
ProjectIDDrug or
challenge
Description and varname PanelStrains
tested
SexAge
Wiltshire3 38101 biomarker quantification fluoxetine cerebral cortex ACTH, relative fluorescence intensity   control   ACTH_cont inbred 30 m 10-11wks
Wiltshire3 38102 biomarker quantification fluoxetine cerebral cortex ACTH, relative fluorescence intensity   fluoxetine   ACTH_fluox inbred 30 m 10-11wks
Wiltshire3 38103 biomarker quantification fluoxetine cerebral cortex ACTH, relative fluorescence intensity   change index   ACTH_index inbred 30 m 10-11wks (supplemental /
  summary measure)